Life sciences briefing: Tuesday, Aug. 28, 2007
Featured companies: ProNAi, Rubicor
ProNAi raises $2M for IV cancer drugs — ProNAi, a Kalamazoo, Mich., biotech focused on intravenous cancer drugs, raised $2 million toward a $4 million bridge round, VentureWire reports (subscription required). The company aims to raise a $25 million second round later tihs… Continue Reading
Sigvion Capital aims for $100M healthcare-startup fund
Sigvion Capital, a Chicago VC firm specializing in life-science investing, hopes to raise between $50 million and $100 million for its second fund, VentureWire reports (subscription required). The firm anticipates a boom in healthcare startups in the Great Lakes region.
Logical Therapeutics raises $30M, relocates to Boston area
Pittsburgh-based Logical Therapeutics, a developer of drugs for inflammation and metabolic disease, raised $30 million in a second funding round and announced it is moving its headquarters to a location “near Boston.” (What are the odds that the new location might be Cambridge, the hub… Continue Reading